TRIM28 and hepatocellular carcinoma: In hepatocellular carcinoma, Zhang et al. reported that UBE2S interacted with intranuclear TRIM28 to accelerate the cell cycle by inducing proteasomal degradation of p27 to support hepatocellular carcinoma development [20].